Apollomics News

HC Wainwright & Co. : Maintain the Apollomics (APLM.US) rating, adjust from buy to buy rating, and adjust the target price from $5.00 to $2.00.

Zhitong FinanceMay 8 14:20

Apollomics Analyst Ratings

BenzingaMay 8 14:11

HC Wainwright & Co. Maintains Buy on Apollomics, Lowers Price Target to $2

BenzingaMay 8 14:12

Maintaining Buy Rating on Apollomics Amid Clinical Setbacks and Pipeline Potential

TipRanksMay 8 05:27

Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)

TipRanksApr 1 05:30

Apollomics Analyst Ratings

BenzingaApr 1 05:16

HC Wainwright & Co. Maintains Buy on Apollomics, Lowers Price Target to $5

BenzingaApr 1 05:18

HC Wainwright & Co. Reiterates Buy on Apollomics, Maintains $17 Price Target

BenzingaNov 20, 2023 05:27

Promising Clinical Trial Results and Global Reach: A Strong Case for Apollomics' Buy Rating

TipRanksNov 20, 2023 05:26

Apollomics Analyst Ratings

BenzingaNov 20, 2023 05:22

Analysts Offer Insights on Financial Companies: Capital Bancorp (CBNK), Apollomics (APLM) and PNC Financial (PNC)

TipRanksOct 24, 2023 05:31

Buy Rating on Apollomics Based on Promising Future Prospects and High Potential of Vebreltinib in Cancer Treatment

TipRanksOct 3, 2023 05:16

Apollomics Analyst Ratings

BenzingaOct 3, 2023 05:14

Apollomics Analyst Ratings

BenzingaAug 23, 2023 03:33

Analysts Are Bullish on These Financial Stocks: Apollomics (APLM), CME Group (CME)

TipRanksJun 5, 2023 05:40

HC Wainwright & Co. Reiterates Buy on Apollomics, Maintains $18 Price Target

BenzingaJun 5, 2023 05:18

HC Wainwright & Co. Initiates Coverage On Apollomics With Buy Rating, Announces Price Target of $18

BenzingaJun 1, 2023 06:30

Apollomics (APLM) Has a New Rating From H.C. Wainwright

TipRanksJun 1, 2023 05:15

EF Hutton Remains a Buy on Apollomics (APLM)

TipRanksMay 25, 2023 11:25

EF Hutton Assumes Apollomics at Buy, Maintains Price Target of $25

BenzingaMay 25, 2023 07:23